| Baylee Jean Lackey, CF-SLP | |
|
303 Lovers Ln, Bowling Green, KY 42103-7935 | |
| (270) 781-5150 | |
| Not Available |
| Full Name | Baylee Jean Lackey |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 303 Lovers Ln, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306524814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 279533 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Baylee Jean Lackey, CF-SLP 249 Greenwood Ln Apt 45, Bowling Green, KY 42104-7947 Ph: () - | Baylee Jean Lackey, CF-SLP 303 Lovers Ln, Bowling Green, KY 42103-7935 Ph: (270) 781-5150 |
News Archive
Roche/Genentech/Chugai's pertuzumab plus trastuzumab (Roche/Genentech/Chugai's Herceptin) and docetaxel (Sanofi's Taxotere, generics) will become Decision Resources' proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015.
Oklahoma State University Medical Center, an osteopathic teaching hospital, was recently purchased from Ardent Health Services by a City of Tulsa trust. As part of the transition of management and operations, the trust launched a plan to improve business management and supply chain processes at Oklahoma State University Medical Center.
CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.
Medical experts say a common malaria drug could have a significant impact on colorectal cancer providing a cheap adjunct to current expensive chemotherapy.
› Verified 2 days ago
Amanda Sadler, M.S. CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5855 Richpond Rd, Bowling Green, KY 42104 Phone: 270-535-1853 | |
Adair Mcalister, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5079 Scottsville Rd, Bowling Green, KY 42104 Phone: 270-999-4626 | |
Cora Spiller, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1053 Lovers Ln, Bowling Green, KY 42103 Phone: 270-807-0335 | |
Mrs. Miranda Mize Hunt, MS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 5079 Scottsville Rd, Bowling Green, KY 42104 Phone: 270-781-2462 | |
Ashley Marie Sterchi, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: The Kid Spot Center, 944 Fields Dr. #102, Bowling Green, KY 42104 Phone: 270-495-1312 | |
Olivia Grace Jones, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 952 Fairview Ave Ste 4, Bowling Green, KY 42101 Phone: 270-938-0101 | |
Mr. Frank Trevor Polson, MSCCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Shive Ln Ste 104, Bowling Green, KY 42103 Phone: 270-576-3303 |